JFG
BNTX icon

Jefferies Financial Group’s BioNTech BNTX Stock Holding History

Jefferies Financial Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$476K – 1767
2025
Q4 		$476K Buy
+5,000
New +$504K ﹤0.01% 1344

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Financial Group's BNTX Position: Q1 2026 in Review

Jefferies Financial Group sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 2,500 shares — an estimated $238K sold.

Jefferies Financial Group first reported a position in BNTX in Q4 2024 and held it in 2 quarters. The position peaked at $570K in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Jefferies Financial Group reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 2,500 BioNTech shares in Q1 2026, an estimated $238K.
  • Jefferies Financial Group first reported a position in BioNTech in Q4 2024 and held it in 2 quarters.
  • Jefferies Financial Group's BioNTech position peaked at $570K in Q4 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.